Business
Harvest One Provides Satipharm CBD Gelpell® Update
Harvest One Provides Satipharm CBD Gelpell® Update Canada NewsWire VANCOUVE...
About this update from Delivra Health Brands Inc
[{"type":"text","content":"\n\n\n\n\nHarvest One Provides Satipharm CBD Gelpell® Update\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\n\nCanada NewsWire\nVANCOUVER, Nov. 6, 2019\n\n\n\nR&D Licence for Canada & Sales Beginning in Argentina\n VANCOUVER, Nov. 6, 2019 /CNW/ - Harvest One Cannabis Inc. (\"Harvest One\" or the \"Company\") (TSX-V: HVT; OTCQX: HRVOF) is pleased to provide an update on its wholly owned subsidiary Satipharm Ltd. (\"Satipharm\") and its proprietary CBD Gelpell® capsules. \n\n \n \n\n \nHarvest One, through its wholly owned licensed producer United Greeneries Ltd., has received permission from Health Canada to import Satipharm's CBD Gelpell® capsules into Canada for research and development purposes. This achievement allows Harvest One to begin compliance testing and analysis for the Canadian market in anticipation of full-scale production in Canada in 2020. \nHarvest One is also pleased to announce that Satipharm's CBD Gelpell® capsules are now available in Argentina for medical purposes, and our initial shipment has been received by the first patient. In March 2017, the Argentine Congress approved a new medical cannabis law. This law authorises the import of cannabis products for sufferers of refractory epilepsy for patients with a doctor's prescription. Satipharm has signed an agreement with FederalMed to manage the importation and distribution of Satipharm's CBD Gelpell® capsules to patients. \n\"At Harvest One, we view the Satipharm CBD Gelpell® capsule as a key part of our health, wellness, and self-care strategy and are very excited to be taking the next step in bringing them to the Canadian market. With this import permit, Harvest One can continue the necessary preparations to bring this unique, effective product to Canada,\" said Grant Froese, Chief Executive Officer of Harvest One. \"We are equally excited to have our first shipment of Satipharm's CBD Gelpell® capsules to Argentina, which marks Harvest One's first entry into South America. This adds to our existing distribution which ...